Topic: Treatment decision-making in castration-resistant prostate cancer
Earn accreditation points
Finish 5 cases, answer 10 questions and Earn 1 credit.
This topic consists of 5 cases
Disease Area: Prostate cancer
Background: The optimal treatment choice/sequence for an individual CRPC patient is challenging. This topic is limited to patients with a castrate testosterone level. Bone-protective agents fall beyond the scope of this topic.
Educational Objective: Gain insight into the appropriate selection of life-prolonging treatments for non-metastatic CRPC (nmCRPC) and metastatic CRPC (mCRPC).
Specialty: Urology, medical oncology
Target Audience: CME (basic, intermediate), Residents (senior)
Latest update: March 1, 2019